|
US2012195952A1
|
|
Implantable matrix having optimum ligand concentrations
|
|
US2012029042A1
|
|
Clonidine for treatment of bone cancer
|
|
US2010160375A1
|
|
Methods and compositions for treating infections comprising a local anesthetic
|
|
US2011027340A1
|
|
Implantable drug depot for weight control
|
|
US2011014259A1
|
|
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US2009263462A1
|
|
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US2009264391A1
|
|
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
